A 37-year-old male with HIV who has recently become symptomatic has begun highly active antiretroviral therapy (HAART). Among the numerous medications that the man now regularly takes are several that inhibit the change of HIV RNA to DNA in a CD4+ cell. Which of the following classes of medications addresses this component of the HIV replication cycle?
A. Protease inhibitors
B. Entry inhibitors
C. Non-nucleoside reverse transcriptase inhibitors
D. Integrase inhibitors